Pharming (PHAR) Tax Provisions (2020 - 2026)

Pharming (PHAR) has 7 years of Tax Provisions data on file, last reported at -$1.9 million in Q2 2026.

• Quarterly Tax Provisions rose 66.94% year-over-year to -$1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2.3 million (up 80.79% YoY) and the FY2025 annual result came in at $10.3 million, up 207.85% from the prior year.
• Tax Provisions fell to -$1.9 million in Q2 2026, from -$459000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $4.5 million in Q1 2023 to a low of -$5.6 million in Q2 2025.
• A 5-year average of -$676000.4 and a median of -$100002.6 in 2022 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 143714385.71% in 2024, down 128807792.31% in 2024.
• Tracing PHAR's Tax Provisions over 5 years: stood at -$4.8 million in 2022, then surged by 100.0% to $2.6 in 2023, then tumbled by 128807792.31% to -$3.3 million in 2024, then jumped by 100.0% to $0.5 in 2025, then slumped by 372200100.0% to -$1.9 million in 2026.
• The last three Tax Provisions figures came in at -$1.9 million (Q2 2026), -$459000.0 (Q1 2026), and $0.5 (Q4 2025), per Business Quant data.